Objective The objective of this study was to review the role of bilateral salpingo‐
oophorectomy in BRCA mutation (m BRCA) carriers and alternative interventions in risk …

Health professionals have shown a growing interest in the therapeutic value of'hope'in
recent years. However, hope has been examined mainly from psychological and biomedical …

Women who have a mutation in the BRCA1 or BRCA2 genes have up to an 87% lifetime risk
of breast cancer and up to a 40% lifetime risk of ovarian cancer. Cancer prevention and …

Background Women with BRCA1 or BRCA2 (BRCA1/2) mutations can reduce cancer
incidence and mortality by using bilateral prophylactic oophorectomy (BPO) or bilateral …

Please cite this paper as: Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A,
Benjamin E, Brunell C, Saridogan E, Gessler S, Oram D, Side L, Rosenthal A, Jacobs I …

Primary surgical prevention in the form of risk-reducing salpingo-oophorectomy (RRSO) is
the most effective option and the gold standard for ovarian cancer (OC) risk-reduction …

Identifying unaffected women with a BRCA mutation can have a significant individual and
population health impact on morbidity and mortality if these women adhere to guidelines for …

For this literature review, medical literature data bases were searched for studies on patient
compliance after genetic risk assessment. The review focused on conditions where …

This study applied the self-regulation model to examine cognitive and emotional predictors
of screening in unaffected women with a strong family history of breast cancer. 748 …

Background Women affected with breast cancer who carry a BRCA1 or BRCA2 (BRCA1/2)
mutation are at risk of developing contralateral breast cancer. To reduce the risk of …